Autoimmune thyroiditis and targeted anti-T cell immunotherapy in man.
Dayan
C M
CM
Charing Cross Sunley Research Centre, London.
Feldmann
M
M
Rapoport
B
B
Londei
M
M
D000818:Animals; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D006111:Graves Disease / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D015994:Incidence; D008713:Methimazole / Q000627:therapeutic use; D051379:Mice; D004676:Myelin Basic Protein / Q000276:immunology; D010446:Peptide Fragments / Q000276:immunology; D015995:Prevalence; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D013967:Thyroiditis, Autoimmune / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*
D000939:Epitopes; D004676:Myelin Basic Protein; D010446:Peptide Fragments; D011948:Receptors, Antigen, T-Cell; D008713:Methimazole